Market Research Logo

HTG Molecular Diagnostics Inc (HTGM) - Product Pipeline Analysis, 2018 Update

Summary

HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems that provide quantitative gene expression analysis in formalin-fixed paraffin embedded tissue. HTG also offers endogenous control array, custom array development, qSelect miRNA gene list, qSelect mRNA gene list, qDiscovery miRNA Version 16, clinical trial support and ingenuity IPA data analysis services, among others. The company serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG is headquartered in Tucson, Arizona, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company HTG Molecular Diagnostics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


HTG Molecular Diagnostics Inc Company Overview
HTG Molecular Diagnostics Inc Company Snapshot HTG Molecular Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview HTG Molecular Diagnostics Inc – Pipeline Analysis Overview HTG Molecular Diagnostics Inc - Key Facts HTG Molecular Diagnostics Inc - Major Products and Services HTG Molecular Diagnostics Inc Pipeline Products by Development Stage HTG Molecular Diagnostics Inc Pipeline Products Overview Breast Cancer Recurrence Risk Score Test Breast Cancer Recurrence Risk Score Test Product Overview CNV Navigator CNV Navigator Product Overview Companion Diagnostic Test - B-Cell Malignancy Companion Diagnostic Test - B-Cell Malignancy Product Overview Companion Diagnostic Test - Tumor Inflammation Companion Diagnostic Test - Tumor Inflammation Product Overview COPD Risk Stratification Test COPD Risk Stratification Test Product Overview Diagnostic Test - Breast Cancer Diagnostic Test - Breast Cancer Product Overview Diagnostic Test - Lung Cancer Diagnostic Test - Lung Cancer Product Overview Diagnostic Test - Lymphoma Diagnostic Test - Lymphoma Product Overview Diagnostic Test - Melanoma Diagnostic Test - Melanoma Product Overview Fusion Navigator Fusion Navigator Product Overview Heart Transplant Rejection Blood Test Heart Transplant Rejection Blood Test Product Overview HTG EdgeSeq ALKPlus Assay HTG EdgeSeq ALKPlus Assay Product Overview HTG EdgeSeq DLBCL Cell of Origin Companion Diagnostic Assay - M7583 HTG EdgeSeq DLBCL Cell of Origin Companion Diagnostic Assay - M7583 Product Overview HTG JANUS HTG JANUS Product Overview Hyper Progressor Test Hyper Progressor Test Product Overview I/O Suite I/O Suite Product Overview Ion PGM Dx System - Cancer Assay Ion PGM Dx System - Cancer Assay Product Overview Ion PGM Dx System - Genetic Disorder Assay Ion PGM Dx System - Genetic Disorder Assay Product Overview NGS-based Theranostic Tool NGS-based Theranostic Tool Product Overview HTG Molecular Diagnostics Inc - Key Competitors HTG Molecular Diagnostics Inc - Key Employees HTG Molecular Diagnostics Inc - Locations And Subsidiaries Head Office Recent Developments HTG Molecular Diagnostics Inc, Recent Developments May 10, 2018: HTG Molecular Diagnostics Reports First Quarter 2018 Results Apr 16, 2018: HTG Promotes John Lubniewski to President and Chief Operating Officer Apr 03, 2018: HTG Announces New Patent for Its Technology Issued in Japan Mar 22, 2018: HTG Molecular Diagnostics Announces Fourth Quarter And Full Year 2017 Results Feb 26, 2018: HTG Announces New Australian Patent for Its Technology Jan 10, 2018: University laboratory at Discovery Park is playing key role in early cancer detection research Jan 04, 2018: HTG Announces Preliminary Fourth Quarter and Full Year 2017 Unaudited Financial Results and Provides Initial 2018 Revenue Guidance Nov 07, 2017: HTG Molecular Diagnostics Reports 2017 Third Quarter Earnings Sep 20, 2017: HTG Announces Issuance of Two Method Patents Related to its Technology Sep 18, 2017: HTG Molecular Diagnostics Receives ISO 13485 Certification for Health Canada CMDCAS Requirements
Appendix
Methodology About GlobalData Contact Us Disclaimer
List of Tables
HTG Molecular Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
HTG Molecular Diagnostics Inc Pipeline Products by Equipment Type
HTG Molecular Diagnostics Inc Pipeline Products by Indication
HTG Molecular Diagnostics Inc, Key Facts
HTG Molecular Diagnostics Inc, Major Products and Services
HTG Molecular Diagnostics Inc Number of Pipeline Products by Development Stage
HTG Molecular Diagnostics Inc Pipeline Products Summary by Development Stage
Breast Cancer Recurrence Risk Score Test - Product Status
Breast Cancer Recurrence Risk Score Test - Product Description
CNV Navigator - Product Status
CNV Navigator - Product Description
Companion Diagnostic Test - B-Cell Malignancy - Product Status
Companion Diagnostic Test - B-Cell Malignancy - Product Description
Companion Diagnostic Test - Tumor Inflammation - Product Status
Companion Diagnostic Test - Tumor Inflammation - Product Description
COPD Risk Stratification Test - Product Status
COPD Risk Stratification Test - Product Description
Diagnostic Test - Breast Cancer - Product Status
Diagnostic Test - Breast Cancer - Product Description
Diagnostic Test - Lung Cancer - Product Status
Diagnostic Test - Lung Cancer - Product Description
Diagnostic Test - Lymphoma - Product Status
Diagnostic Test - Lymphoma - Product Description
Diagnostic Test - Melanoma - Product Status
Diagnostic Test - Melanoma - Product Description
Fusion Navigator - Product Status
Fusion Navigator - Product Description
Heart Transplant Rejection Blood Test - Product Status
Heart Transplant Rejection Blood Test - Product Description
HTG EdgeSeq ALKPlus Assay - Product Status
HTG EdgeSeq ALKPlus Assay - Product Description
HTG EdgeSeq DLBCL Cell of Origin Companion Diagnostic Assay - M7583 - Product Status
HTG EdgeSeq DLBCL Cell of Origin Companion Diagnostic Assay - M7583 - Product Description
HTG JANUS - Product Status
HTG JANUS - Product Description
Hyper Progressor Test - Product Status
Hyper Progressor Test - Product Description
I/O Suite - Product Status
I/O Suite - Product Description
Ion PGM Dx System - Cancer Assay - Product Status
Ion PGM Dx System - Cancer Assay - Product Description
Ion PGM Dx System - Genetic Disorder Assay - Product Status
Ion PGM Dx System - Genetic Disorder Assay - Product Description
NGS-based Theranostic Tool - Product Status
NGS-based Theranostic Tool - Product Description
HTG Molecular Diagnostics Inc, Key Employees
Glossary
List of Figures
HTG Molecular Diagnostics Inc Pipeline Products by Equipment Type
HTG Molecular Diagnostics Inc Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report